IFNA1 and neoplasm: This loss of IFNγ receptor signaling allows the tumor to evade the effects of IFNγ produced by anti-tumor T cells that would reduce tumor antigen presentation capability, decrease the expression of IFN-associated chemoattractants and promote insensitivity to the anti-proliferative and pro-apoptotic effects of IFNγ in tumor cells.